Trailing Twelve Months

(redirected from Last twelve months)
Also found in: Acronyms.

Trailing Twelve Months

Referring to the most recently completed 12 month period. For example, trailing 12 month earnings refers to a company's earnings over the 12 months ending on the last day of the most recent month. Showing developments on a trailing 12 month basis is common way of tracking a company's finances. It is less commonly called last 12 months.
Mentioned in ?
References in periodicals archive ?
Over the last twelve months, exports have been growing at an annualized rate of 9.
The group said its pro-forma results are presented as if the group had been trading in its current form for the last twelve months
Over the last twelve months Apollo has been involved in a number of major European deals including the acquisition of a portfolio of 26 shopping centers anchored by Metro for a total consideration in excess of 700 million [euro] and the sale of its holding in Haslemere NV.
The net sales during the last twelve months of the review period, 1 January-31 December 2001, were EUR36.
for investment banking services within the last twelve months and Rodman & Renshaw, LLC intends to seek compensation from Biomira, Inc.
The total estimated value of agreements signed between PKN ORLEN and companies from Eni group in the last twelve months amounts to approximately PLN 2 306 million.
Over the last twelve months, among the major export markets, the countries with the largest annualized increase in U.
The latest bi-annual 50 Centres Guide to prime retail rents from Jones Lang LaSalle shows that Birmingham recorded a top rent in excess of pounds 325 per sq ft in the last twelve months.
In the last twelve months, BIS technology was used in approximately 16 percent of all U.
In the last twelve months 51 million new connections were started, an activation rate of 1.
Over the last twelve months, the major export markets with the largest annualized increase in purchases of U.
Rodman & Renshaw, LLC or its affiliates did receive compensation from Accentia Biopharmaceuticals for investment banking services within the last twelve months and Rodman & Renshaw, LLC intends to seek compensation from Accentia Biopharmaceuticals for investment banking services within three months, following publication of the research report.